Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
1
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
 283
innovative chemical compounds that are capable of treating diseases caused by bacteria that are resistant to several drugs. It is extremely necessary to find novel compounds in nature to produce new antibacterial compounds. In recent years, there has been a change in secondary metabolites that are employed in antimicrobial medications. Actinobac­teria has become the dominant source of these compounds. Marine bioactive chemicals including polyphenols, proteins, and essential fatty acids possess different biological effects such as antioxidant, antithrombotic, anticoagulant, anti-inflammatory, antipro­liferative, hypotensive, diabetic, and cardioprotective properties (Table 13.1). The food industry may also profit from the advantageous rheological qualities that they possess (Ameen et al., 2021).

13.3 ANTICANCER ACTIVITY OF MARINE PLANTS

Almost 90% of the ocean’s total biomass comprises various types of marine flora. They are plentiful, taxonomically varied, physiologically active, and chemically distinct, all of which make them excellent candidates for the research that might lead to the development of novel cancer therapies. Polyphenols with sulfated polysaccharides, for example, are two examples of chemicals found in marine flora that may have medical use. The compounds have shown a broad variety of pharmacological characteristics, including anticancer, immunostimulatory, and antioxidant properties. It is possible that phytochemicals might prevent carcinogenesis by boosting macrophage activity, causing cells to commit suicide (apoptosis), and shielding DNA from oxidative damage. Sea plants contain large untapped reserves that have been chemically enhanced, but researchers are most interested in possible compounds that might combat cancer. This chapter ’s objective is to promote additional research into the anticancer properties of marine flora in light of rising prevalence of cancer and the lack of readily available, low-risk, and highly efficient medicines to treat this dreadful human disease. Marine flora has been shown to possess these properties (Manoharan and Perumal, 2022).
As a consequence of alterations in diet, changes in lifestyle, and increased environmental stress, the incidence of cancer, a terrible illness that affects people, is on the rise. Cancer treatments are now suffering from a lack of accessible medications that are effective, in part because of the negative effects that are associated with the currently available treatments. In this context, naturally occurring compounds that are produced from medicinal plants have become more important. More than half of all medications that are administered in clinical settings across the world are derived in some way from natural materials or are produced by using these natural materials (Hegde and Chen, 2020). The contribution of higher plants is guaranteed to be at least 25% of the total. Over 60% of cancer treatments are derived from other natural sources. Fruits and vegetables include a high concentration
of cancer-ghting elements such as vitamins (B, C, and E), carotenoids, and ber. Fruits and
vegetables are also rich in antioxidants. The life expectancy increases in direct proportion to the quantity of natural antioxidants that are eaten, decreasing the chances of occurrence of cardiovascular diseases and cancer. During the last three decades, there has been a boom of herbal medicine formulations for preventing and treating cancer, and research into
TABLE 13.1 Marine-Derived Bioactive Metabolites Along With Their Potential Applications (Nair and Abraham, 2020; Hamed et al., 2024)
S. No. Secondary Metabolites Marine Species Applications
Anticancerous
1. Aureoverticillactam
2. Caprolactones
3. Chinikomycins
4. IB-00208
5. Salinosporamide A (NPI-0052)
6. Urdamycin
7. Niphateolide
8. Hexylitaconic acid
9. Lissoclinidine B
10. Himeic acid A
Antibacterial
11. Abyssomicins
12. Frigocyclinone
13. Gutingimycin
14. Helquinoline
15. Himalomycins
16. Maklamicin
17. Lobophorin K
18. Asenjonamide C Antibacterial and anticancerous
19. 1-hydroxy-1-norresistomycin
Antifungal and antibacterial
20. Bonactin
Antiprotease and anticancerous
21. Diazepinomicin (ECO-4601)
Aspergillus aureofaciens Streptomyces sp. Streptomyces sp. Streptomyces sp. Actinomadura sp. Salinisporatropica
Streptomyces fradiae Niphatesolemda
Arthrinium sp. Lissoclinumcf. badium Aspergillus sp.
Verrucosispora sp. Blocks p-aminobenzoic acid (chorismate) route Streptomyces griseus Streptomyces sp. Janibacterlimosus Streptomyces sp. Micromonosporasp.strain Streptomyces sp. strain M-207 Streptomyces asenjoniistrain KNN 42
Streptomyces variabilis In vitro cytotoxicity against HMO2 (gastric adenocarcinoma) and HePG2
Streptomyces sp.
Micromonosproa sp.
GMKU326
Cytotoxicity against a range of tumor cells Activity against cancer cell lines Anticancer activity across multiple cancer cell lines in humans Cancer cell-line cytotoxicity and Gram-positive bacteria-killing potential Proteasome and NF-B inhibition
Anticancer activity
Blocker of the p53-Hdm2/Mdm2 interaction Blocker of p53/Mdm2 binding
Destroys wild-type p53-altered cells Inhibitory effects on ubiquitin-activating enzyme (E1)
Kaposi’s sarcoma-associated herpes virus inhibitor Activities against bacteria, fungi, and microalgae
Activities against bacteria, fungi, and microalgae Activities against Gram-positive bacteria Inhibition of the growth of Gram-positive bacteria Ac as antibiotic for Gram-positive pathogens Antimicrobial for Gram-positive pathogens
(hepatic cancer) cell lines
Inhibited Gram-positive bacteria and fungi
Broad-spectrum preliminary anticancer, antioxidant, and antiprotease activity
⏎
284 
 285
prospective chemotherapeutic drugs derived from natural sources is still being undertaken today (Gallagher and LeRoith, 2020).
In the later stages of the development of cancer, antioxidants are very necessary. Even though the particular mechanisms underlying this are still being investigated, there is a growing body of evidence that oxidative processes have a role in the development of cancer. Antioxidants have the potential to stop the spread of precancerous lesions and their
development into cancer. Early research indicates that β-carotene and other antioxidants
might be advantageous in dealing and anticipation of oral leukoplakia, which is a disorder that has the potential to progress into mouth cancer. It is well recognized that natural foods are high in β-carotene, α-tocopherol, and vitamins C and E. This indicates that plant extracts and isolated components of plant origin may be examined for their potential antioxidative and anticancer activities, which might lead to the creation of new anticancer medicines (Vishwakarma and Piddini, 2020).

13.4 ANTICANCER AGENTS FROM MARINE FLORAS

The use of novel bioactive compounds found in marine microorganisms is anticipated to result in the development of new medicines and targets. Bryostatins, discodermolide, eleutherobin, and sarcodictyin are only a few examples of the innovative anti-inflammatory , anticancer, and antibiotic medicinal compounds that have been made from secondary metabolites generated by marine bacteria (e.g., marinone). By producing bacteriocines, an antibacterial protein, and other anticancer compounds, probiotic bacteria such as lactobacilli and bifid bacteria play foremost responsibilities in the regulation of pathogenic germs. According to reports, lactobacilli dietary supplements reduce the development of experimental colon cancer. By acting on NF-B pathways, dendritic cell maturation is influenced and anti-inflammatory cytokines such as IL-10 that horde defence peptides such as defensing 2 are produced at a higher rate. IgA defences are also strengthened. Cellular response to short-chain fatty acids is another mechanism by which they regulate cell growth and death (Varijakzhan et al., 2021). The majority of marine animal phyla create poisons, and research suggests that the marine bacteria that live with the animals may also be producing these toxins. Studies on neurophysiology and neuropharmacology may benefit from the microbial poisons. For instance, crimson tides are brought on by bacteria found in Noctiluca scintillans. Macrolactin-A is a primary metabolite that inhibits the growth of B16-F10 murine melanoma cancer cells and types I and II of mammalian herpes simplex virus. It also protects T lymphocytes from HIV replication. In Hawaii, the mollusk Elysia rubefescens produced depsipeptides known as kahalalide F (KF), which is thought to have been produced by microorganisms connected to animals. KF demonstrates intriguing selectivity in its activity against solid tumors when evaluated in vitro on prostate cancer cell lines. Extensive in vivo studies also reveal drug’s efficacy in treating colon and breast cancers. Because very few marine microorganisms are amenable to isolation in the laboratory , there is a pressing need to establish new culture methods for the identification of slow-growing bacteria and bacteria that are unique in producing novel natural compounds (Ghosh et al., 2022).
286 
13.5 MECHANISM OF ANTICANCEROUS ACTIVITY EXHIBITED BY MARINE
PLANTS
It is generally accepted that DNA damage plays an important role in the mechanism through which cancer develops. It would be helpful to have a measurement of the mutagenic DNA damage to estimate the risk of cancer in different populations and to monitor property of chemoprevention. The oxidative component is responsible for the vast majority of these issues. Repairing the majority of the damage is the job of enzymes that work on repairing DNA. The accumulation of the free radical damage to DNA that occurs with ageing makes it more probable that a person may get cancer (Fayed et al., 2021).

13.5.1 ANTIOXIDANTS

The human body is equipped with a variety of defense mechanisms that it uses to combat free radicals and reactive oxygen species (ROS). Because different defenses act on various classes of oxidants or in various compartments of the cell, they are mutually supportive of one another. In most circumstances, the presence of high amounts of superoxide dismutase (SOD) maintains levels of superoxide that are not sufficient to prevent the formation of Peroxynitrite. Although glutathione (GSH) is not a food, it exists in all the aerobic tissues because it can be synthesized from sulfhydryl group containing amino acids. It has a very significant role in the metabolic process of antioxidant intermediates. Consuming nutritious foods on a regular basis is critical for the proper functioning of enzymes that shield the body from damaging effects of free radicals (Carreira-Casais et al., 2021). A few instances of essential components required for the structure or catalytic functions of such enzymes are selenium, copper, manganese, and zinc. Vitamin E, on the other hand, is not associated with the activity of any single-enzyme system. Vitamin E functions as an antioxidant by eliminating free radicals and preserves the structural integrity of phospholipid and lipid membranes. V itamin E has a significant impact on other antioxidants already present in the body , for instance, GSH and vitamin C. Evidence is mounting that vitamin E can influence cellular processes like gene expression and inflammatory response. Vitamin C is also a potent antioxidant since it may donate an electron of hydrogen in exchange for the formation of the comparatively stable ascorbyl free radical or L-ascorbate anion. It has been shown that ascorbate is an effective reactive oxygen species scavenger against singlet oxygen, hydrogen peroxide, hydroxyl radical, and superoxide radical anion. In addition, dangerous nitrogen oxide species are also eliminated by vitamin C. To prevent the target molecules from getting nitrosated, it works in this way. Ascorbyl has the potential to undergo further oxidation, which would result in the formation of dehydroascorbate. Alternatively, it might acquire an additional hydrogen atom and transform into reduced ascorbate. Ascorbate is more water-soluble than dehydroascorbate, and erythrocytes absorb dehydroascorbate 10–20 times more quickly than ascorbate. The hexose monophosphate shunt then converts it back into ascorbate, either via GSH or Nicotinamide adenine dinucleotide phosphate (NADPH). Therefore, there is no limit to the mechanisms in which vitamin C can be used. Tissue metabolism generates free radicals, but the cell’s antioxidant capacity and its repair
 287
systems work together to limit their damage. So, a healthy individual who consumes an enough amount of food and has tissue cells that are metabolically active will have little tissue damage, and if damage does occur, the majority of it will be cured (Xu et al., 2021).

13.5.2 IMMUNOMODULATION AND APOPTOSIS

The intricate process of apoptosis causes a variety of alterations in the dying cells and utilizes several signaling channels. A change in the ratio of anti- and pro-apoptotic proteins activates apoptotic machinery. Apoptosis may be reduced by upregulating antiapoptotic proteins, downregulating proapoptotic proteins, and downregulating caspase expression. It is known that evading apoptosis speeds up the growth of cancer by preventing differentiation. In conditions when there is inadequate apoptosis, which results in cancer, dysregulation of apoptotic signaling may be very important. Caspase 8 is a mitochondrial initiator caspase that promotes cytochrome C release and links death receptor with mitochondrial pathways of apoptosis. Caspase 3 is a cell-killing effector caspase that is required for cell survival. Apoptosis induction is a promising strategy for inhibiting cancer cell proliferation (Matulja et al., 2022). Cancer has been treated with radiation and chemicals such as tamoxifen, which may induce apoptosis. Several chemo-preventive substances cause apoptosis to have an anticarcinogenic effect. Plant extracts’ ability to induce apoptosis of malignant cells may be linked to upregulated immune surveillance, an increase in macrophages, and activation of signal complexes that cause death. Malignant cells have been shown to undergo apoptosis in vitro when exposed to natural food components such as curcumin and resveratrol. The macrophages may be stimulated and made to undergo apoptosis by the marine phytochemicals (Yao et al., 2022). Fucoidan, an immunomodulator that directly affects macrophage and T lymphocyte, is derived from the Laminaria japonica plant and may restore the immunological capabilities of immunosuppressed mice. In rats exposed to radiation, it may also encourage the restoration of immune function. The mechanism is connected to the fucoidans ability to stop lymphocyte apoptosis. Dendritic cells that are potent antigen-presenting cells are affected by fucoidan from Focus vesiculosus in an immunostimulant and growing method via a nuclear factor-B route (NF-κB) (Yarley et al., 2021).

13.5.3 NUTRITIONAL VALUES AND ANTICANCER EFFECTS

Marine plants are expected to meet the need for food and nutrients for handling human ailments. The majority of cancer-preventive diets focus on including foods that come from plants as their primary source of nutrition. A higher frequency of consumption of a wide variety of plant foods is recommended for cancer prevention. “Plant-based” diets place more emphasis on nutrient-dense, fiber-rich (and thus, nonstarch polysaccharide-rich), and calorie­poor foods. Consuming a diet rich in fruits and vegetables that are low in starch may reduce the risk of developing some cancers. Seaweeds are often ingested by people and have been used medicinally for a very long time. Seaweeds possess many unique biological features against tuberculosis, arthritis, colds, influenza, cancer, and so on (Yusefi
et al., 2020).
288 
Most of individuals unknowingly utilize products containing seaweed on a daily basis. Many processed foods, particularly processed dairy, meat, and fruits, contain these substances. Other common products that contain them include paint, dental products, and even some paints. Seaweeds are an outstanding source of several nutrients, including the minerals calcium, phosphorus, sodium, and potassium, and vitamins. They have a healthy mix of amino acids and contain almost all of the essential amino acids necessary for survival and good health. They possess more than 54 trace elements, which are essential for the physiological processes that take place in the human body (Gopeechund et al., 2020).

13.6 NATURE AND CANCER CHEMOTHERAPY

According to recent studies conducted during the last half-century, it has been observed that several natural chemicals originating from marine plants and microorganisms have been shown to be effective for the treatment and prevention of cancer . Cytarabine, eribulin mesylate, brentuximab vedotin, and trabectedin are only a few of the drugs that have been originated from marine sources. These drugs are administered to the patients depending upon the type of cancer being treated. There are other important terrestrial sources of anticancer medicines including plants, animals, invertebrates, and microorganisms. Vincristine and vinblastine both of which are active complex alkaloid chemicals found in the Vinca plant when combined with antineoplastic drugs such as taxol that originate from the outer layer of the bark of Western Yew tree have shown promising results in the treatment of breast cancer. It has been shown that both vincristine and vinblastine are effective therapies for juvenile leukemia as well as for choriocarcinoma that is a cancer of the lymph nodes caused by Hodgkin’s disease (Okem et al., 2023). Traditional medical practices for treating a wide range of conditions historically made extensive use of natural compounds derived from plants. With the advent of “modern” medicine, which is found through scientific research, natural remedies that are plant-based have been subjected to intense scrutiny due to the lack of empirical evidence supporting their effectiveness. Despite this, researchers have kept seeking for systematic verification to support the use of functional meals, therapeutic plants, and herbal medications. Because of the emphasis on the research and development of medicinal plant-based active prin­ciples in recent decades, a significant amount of headway has been achieved in both the discovery and the use of naturally occurring compounds in the treatment of a wide range of illnesses (Figure 13.2). The knowledge about medicinal plants and the therapeutic properties they possess originates from either traditional Chinese or Indian medicine. Approximately, 25–28% of the modern drugs used by humans, including those used to treat cancer, have been obtained either directly or indirectly from plants or other natural sources (Yahyea Baktiar et al., 2020).
Global economic and social systems have largely been impacted by cancer, as it is the leading cause of mortality worldwide. It is necessary to develop cancer prevention strategies for those who are at risk and to improve cancer treatment strategies for individuals who have already been diagnosed with the condition. There is a very small fraction of cancer cases that may be attributed to hereditary or genetic vulnerability . Cancers typically develop
 289
over a period of years or even decades, and their onset can be attributed to a wide range of causes. These causes include DNA damage, epigenetic changes, metabolic changes,
persistent inammation, and interactions between abnormal molecular pathways, apoptosis
inhibition, and cellular communication with nearby tissues. Surprisingly, natural chemicals that are derived from plants have the potential to target one or more of the mechanisms that induce neoplasticity (Figure 13.1). By doing so, these natural substances may be able to stop cancer from initiating, developing, spreading, or relapsing (Shen et al., 2021).
Despite the strong chemical reasoning, cancer chemoprevention employing marine natural chemicals has not been explored extensively, and clinical and preclinical data for this technique is limited. Plants, bacteria, and marine organisms are the biological sources that have yielded chemicals with anticancer characteristics that have been recognized and synthesized. As a consequence, abundant natural products are now being considered in preclinical research, and 13 natural compounds derived from marine organisms are presently being considered in clinical trials at varying levels. These recent advancements highlight the potential of natural compounds found in marine environments. It has been hypothesized that a focused and combinatorial approach might speed up the expansion of innovative anticancer agents resulting from marine resources that are more effective and have fewer side effects (Figure 13.2).
FIGURE 13.1 Pharmacological effects of natural compounds in various diseases. Source: Reprinted from Samuel
https://creativecommons.org/licenses/by/4.0/
et al. (2021). Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
⏎
290 
FIGURE 13.2 Natural sources with anticancer compounds.
Source:
Adapted from Khalifa et al. (2019). Copyright © 2019 by the authors. Licensee MDPI, Basel,
Switzerland. http://creativecommons.org/licenses/by/4.0/
⏎

13.7 MARINE ORGANISMS AND CANCER CHEMOTHERAPY

Much effort has been put to discover new anticancer medicines that originate from natural sources due to the pressing need for anticancer therapeutics with novel mechanisms of action. Some examples of these natural resources are marine life, bacteria, and plants. Marine populations operate as a reservoir for new bioactive metabolites (Santaniello et al.,
2023). In this chapter, the importance of marine organisms, marine sponges, and other marine organisms including soft corals, seaweeds, algae, bacteria, actinomycetes, and fungi has been described in preventing growth of tumors, as well as the associated compound­induced apoptosis and cytotoxicity. In addition to this, several molecular routes leading to the biological effects have been discussed. The use of marine-derived components in therapeutic procedures, in addition to its present state and possible future prospects, has also been discussed (Figure 13.3).
There are approximately 500 × 106 different species of prokaryotic and eukaryotic creatures that are known to exist in the earth. The marine environment is home to an
30
estimated 3.7 × 10
microorganisms. To protect themselves from predators and harsh environmental circumstances such as high temperatures, high salinity, and high pressure, marine organisms develop secondary metabolites (Sekar et al., 2022).
 291
Sea plants have been used for their therapeutic value by Asia, the Middle East, and Europe for endless millennia. Since that time, scientists have only investigated around 5% of the deep water, and only approximately 1% of the ocean bottom has been thoroughly researched. Chemical study on marine species did not get started until after substantial work was done on the Caribbean sponge (Cryptotethya crypta). In the years 1950 and 1960, scientists used phytochemical methods to investigate the pure substances that might be extracted from this plant (Ara-C). In addition, a number of marine creatures including bacteria, actinobacteria, cyanobacteria, fungi have been studied to see whether or not they possess any potential anticancer properties. In clinical studies, the effectiveness of bioac­tive compounds against a variety of cancer forms has been investigated and analyzed. In addition, as marine chemistry advances, new technologies such as metabolomics are being
used to analyze marine products (Püsküllüoğlu and Michalak, 2022).
Approximately 22,000 secondary metabolites have been reported to be produced by microbes, with actinomycetes producing 70%, fungi producing 20%, Bacillus sp. producing 7%, and other bacteria contributing 1%–2% of these compounds. It is important to keep in mind that microbes are generally the source of 10% of all naturally occurring biologi­cally active chemicals that are currently being recognized. There are few marine anticancer medicines that have been tested successfully in clinical trials. Second phase of bryostatin 1 clinical study has begun assessing the drug’s effectiveness against malignancies of the colon, kidney, non-Hodgkin’s lymphoma, and skin. Bryostatin 1 encourages the produc­tion of progenitor cells in bone marrow. In addition, the peptide dolastatin 10, which was derived from the mollusk Dollabella auricularia, has progressed to phase II clinical trial stage owing to its ability to prevent the construction of microtubules, which eventually leads to metaphase arrest in T cells (Montuori et al., 2022).

13.8 ANTICANCER AGENTS FROM MARINE FLORAS

Marine algae make up 65.63% of all the anticancer compounds that have been discovered so far, with mangroves coming in second with 28.12% and bacteria coming in third with
6.25%. Because of the complex chemical ecology of marine organisms, including marine flora, there is a significant possibility that marine species, in particular marine flora, could be used to develop anticancer drugs that are effective, affordable, and safe.

13.9 MARINE PLANTS

Algae make up more than 90% of all marine plant species (Abdelhamid et al., 2020).

13.9.1 MACRO ALGAE (SEAWEED)

In addition to providing essential nutrients such as protein and iodine, seaweeds’ metabolites have demonstrated promising anticancer benefits. Within the past three decades, there have
292 
been a number of investigations into the antioxidant, anticancer, and immunomodulatory properties of seaweeds. It has been shown that certain types of edible seaweed such as Palmaria palmate are rich in antioxidants that inhibit the development of cancer cells. Red algae Acanthophora spicifera has tumorcidal activity on mice that have developed Ehrlich’ s
ascites carcinoma cells at dosage of 20 mg/kg, which is comparable to conventional medicine
5-flurouracil in terms of its anticancer effects. This is shown by the longer median survival time, lower tumor volume, and higher viable cell count. In smear examination, membrane blebbing, the creation of vacuoles, and a reduction in staining intensity may be recognized as further indications of tumorcidal activity (Singh et al., 2020) (Figure 13.3).
FIGURE 13.3 Marine drugs and compounds utilized in clinical trials, its sources, and chemical classes. Source: Reprinted from El-Bondkly
et al. (2021). Copyright © 2021 The Authors. Published by Elsevier Ltd.

13.9.2 MANGROVES AND OTHER HIGHER PLANTS

Fisher-folk medicine has historically employed mangroves to heal illnesses. 2-benzoxa­zoline ribose derivative of Acanthus ilicifolius has been studied for its antiviral and anti­cancer effects. Ceriops decandra tea has been demonstrated to reduce dimethyl Benz [a] anthracine-induced buccal pouch carcinogenesis in hamsters (Denny, 2021).